Nieuwdorp M - Search Results

1

The gut microbiome, a hidden endocrine organ with widespread metabolic implications?

Hanssen NMJ, Nieuwdorp M. Hanssen NMJ, et al. Among authors: nieuwdorp m. Best Pract Res Clin Endocrinol Metab. 2021 May;35(3):101543. doi: 10.1016/j.beem.2021.101543. Epub 2021 May 5. Best Pract Res Clin Endocrinol Metab. 2021. PMID: 33992532 No abstract available.

2

Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?

Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Vrieze A, et al. Among authors: nieuwdorp m. Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):127-37. doi: 10.1016/j.bpg.2013.03.003. Best Pract Res Clin Gastroenterol. 2013. PMID: 23768558 Review.

3

About the gut microbiome as a pharmacological target in atherosclerosis.

Witjes JJ, van Raalte DH, Nieuwdorp M. Witjes JJ, et al. Among authors: nieuwdorp m. Eur J Pharmacol. 2015 Sep 15;763(Pt A):75-8. doi: 10.1016/j.ejphar.2015.06.023. Epub 2015 Jun 18. Eur J Pharmacol. 2015. PMID: 26096558 Review.

4

Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.

Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. Bouter KE, et al. Among authors: nieuwdorp m. Gastroenterology. 2017 May;152(7):1671-1678. doi: 10.1053/j.gastro.2016.12.048. Epub 2017 Feb 10. Gastroenterology. 2017. PMID: 28192102 Review.

5

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.

Aydin Ö, Nieuwdorp M, Gerdes V. Aydin Ö, et al. Among authors: nieuwdorp m. Curr Diab Rep. 2018 Jun 21;18(8):55. doi: 10.1007/s11892-018-1020-6. Curr Diab Rep. 2018. PMID: 29931613 Free PMC article. Review.

6

Does disease start in the mouth, the gut or both?

Prodan A, Levin E, Nieuwdorp M. Prodan A, et al. Among authors: nieuwdorp m. Elife. 2019 Mar 19;8:e45931. doi: 10.7554/eLife.45931. Elife. 2019. PMID: 30885294 Free PMC article.

7

Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.

van Bommel EJM, Herrema H, Davids M, Kramer MHH, Nieuwdorp M, van Raalte DH. van Bommel EJM, et al. Among authors: nieuwdorp m. Diabetes Metab. 2020 Apr;46(2):164-168. doi: 10.1016/j.diabet.2019.11.005. Epub 2019 Dec 6. Diabetes Metab. 2020. PMID: 31816432 Clinical Trial.

8

Gut microbiota: a promising target against cardiometabolic diseases.

Warmbrunn MV, Herrema H, Aron-Wisnewsky J, Soeters MR, Van Raalte DH, Nieuwdorp M. Warmbrunn MV, et al. Among authors: nieuwdorp m. Expert Rev Endocrinol Metab. 2020 Jan;15(1):13-27. doi: 10.1080/17446651.2020.1720511. Expert Rev Endocrinol Metab. 2020. PMID: 32066294 Review.

9

Microbiome and Cardiovascular Disease.

Herrema H, Nieuwdorp M, Groen AK. Herrema H, et al. Among authors: nieuwdorp m. Handb Exp Pharmacol. 2022;270:311-334. doi: 10.1007/164_2020_356. Handb Exp Pharmacol. 2022. PMID: 32185503

10

Gut microbiota and metabolites in the pathogenesis of endocrine disease.

Fenneman AC, Rampanelli E, Yin YS, Ames J, Blaser MJ, Fliers E, Nieuwdorp M. Fenneman AC, et al. Among authors: nieuwdorp m. Biochem Soc Trans. 2020 Jun 30;48(3):915-931. doi: 10.1042/BST20190686. Biochem Soc Trans. 2020. PMID: 32412045 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page